Home Recalls D-0941-2023
Class II · Moderate risk Ongoing Initiated Jun 22, 2023 (3 years ago)
Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Defective Delivery System
What was recalled
Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Division) Karakhadi, Vadodara 391450, India. NDC 62332-487-12
Recalling firm Alembic Pharmaceuticals, INC.
NDC code 62332-487-12
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0941-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jan 27, 2026
Reason Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Class III · Low risk Ongoing Dec 22, 2025
Reason Failed PH Specifications
Class II · Moderate risk Terminated Mar 24, 2022
Reason CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability…
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.